Consequences of bile salt biotransformations by intestinal bacteria

References

• Hardison WG. Hepatic taurine concentration and dietary taurine as regulators of bile acid conjugation with taurine. Gastroenterology 1978; 75(1):71–5; PMID:401099
   PubMed Web of Science ®Google Scholar
• Dawaon PA, Karpen SJ. J Lipid Res 2015; 56(6):1085–99; PMID:25210150; http://dx.doi.org/10.1194/jlr.R054114
   PubMed Web of Science ®Google Scholar
• Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig, KD, Mangelsdorf, DJ, Shan B. Identification of a nuclear receptor for bile acids. Science 1999; 284:1362–5; PMID:10334992; http://dx.doi.org/10.1126/science.284.5418.1362
   PubMed Web of Science ®Google Scholar
• Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Wilson TM, Zavacki AM, Moore DD, et al. Bile acids: natural ligands for an orphan nuclear receptor. Science 1999; 284:1365-8.
   Web of Science ®Google Scholar
• Kawamata Y, Fujii  R, Hosoya M, Harada M, Yoshida H, Miwa M, Fukusumi S, Habata Y, Itoh T, Shintani Y et al. A G-protein-coupled receptor responsive to bile acids. J Biol Chem 2003; 278:9435–40
   PubMed Web of Science ®Google Scholar
• Li T, Chiang JY. Bile acids as metabolic reglators. Curr Opin Gastroenterol 2015; 31(2):159–65; PMID:25584736; http://dx.doi.org/10.1097/MOG.0000000000-000156
   PubMed Web of Science ®Google Scholar
• D'Aldebert E, Biyeyeme Bi Mve MJ, Mergey M, Wendum D, Firrincieli D, Coilly A, Fouassier L, Corpechot C, Poupon R, Housset C, et al. Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium. Gastroenterology 2009; 136(4):1435–43; PMID:19245866; http://dx.doi.org/10.1053/j.gastro.2008.12.040
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006; 47(2):241–59; PMID:16299351; http://dx.doi.org/10.1194/jlr.R500013-JLR200
   PubMed Web of Science ®Google Scholar
• Alnouti Y, Csanaky IL, Klaassen CD. Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 873(2):209–17; PMID:18801708; http://dx.doi.org/10.1016/j.jchromb.2008.08.018
   PubMed Web of Science ®Google Scholar
• Vlahcevic ZR, Heuman DM, Hylemon PB. Physiology and pathophysiology of enterohepatic circulation of bile acids. In Hepatology: A Textbook of Liver Disease. 3rd edition. Vol. 1. D. Zakim and T. Boyer, editors. Saunders, Philadelphia, PA. 1996. 376–417.
   Google Scholar
• Sjövall J. Dietary glycine and taurine on bile acid conjugation in man:bile acids and steroids 75. Proc Soc Exp Biol Med 1959; 100:676–78; PMID:13645682; http://dx.doi.org/10.3181/00379727-100-24741
   PubMed Web of Science ®Google Scholar
• Gopal-Srivastava R, Hylemon PB. Purification and characterization of bile salt hydrolase from Clostridium perfringens. J Lipid Res 1988; 29(8):1079–85; PMID:2903208
   PubMed Web of Science ®Google Scholar
• Masuda N. Deconjugation of bile salts by Bacteroides and Clostridium. Microbiol Immunol 1981; 25(1):1–11; PMID:6265737; http://dx.doi.org/10.1111/j.1348-0421.1981.tb00001.x
   PubMed Web of Science ®Google Scholar
• Wijaya A, Hermann A, Abriouel H, Specht I, Yousif NM, Holzapfel WH, Franz CM. Cloning of the bile salt hydrolase (bsh) gene from Enterococcus faecium FAIR-E 345 and chromosomal location of bsh genes from food enterococci. J Food Prot 2004; 67(12):2772–8; PMID:15633685
   PubMed Web of Science ®Google Scholar
• Jarocki P, Targoński Z. Genetic diversity of bile salt hydrolases among human intestinal bifidobacteria. Curr Microbiol 2013; 67(3):286–92; PMID:23591474; http://dx.doi.org/10.1007/s00284-013-0362-1
   PubMed Web of Science ®Google Scholar
• Tanaka H, Hashiba H, Kok J, Mierau I. Bile salt hydrolase of Bifidobacterium longum biochemical and genetic characterization. Appl Environ Microbiol 2000; 66(6):2502–12; PMID:10831430; http://dx.doi.org/10.1128/AEM.66.6.2502-2512.2000
   PubMed Web of Science ®Google Scholar
• Oh HK, Lee JY, Lim SJ, Kim MJ, Kim JH, Hong SK, Kang DK. Molecular cloning and characterization of a bile salt hydrolase from Lactobacillus acidophilus PF01. J Microbiol Biotechnol 2008; 18(3):449-56.1; PMID:18388461
   PubMedGoogle Scholar
• De Smet I, Van Hoorde L, Vande Woestyne M, Christiaens H, Verstraete W. Significance of bile salt hydrolytic activities of lactobacilli. J Appl Bacteriol 1995; 79(3):292–301; PMID:7592123; http://dx.doi.org/10.1111/j.1365-2672.1995.tb03140.x
   PubMedGoogle Scholar
• Stellwag EJ, Hylemon PB. Purification and characterization of bile salt hydrolase from Bacteroides fragilis subsp. fragilis. Biochim Biophys Acta 1976; 452(1):165–76; PMID:10993; http://dx.doi.org/10.1016/0005-2744(76)90068-1
   PubMed Web of Science ®Google Scholar
• Jones BV, Begley M, Hill C, Gahan CG, Marchesi JR. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci USA 2008; 105(36):13580–5; PMID:18757757; http://dx.doi.org/10.1073/pnas.0804437105
   PubMed Web of Science ®Google Scholar
• Kim GB, Miyamoto CM, Meighen EA, Lee BH. Cloning and characterization of the bile salt hydrolase genes (bsh) from Bifidobacterium bifidum strains. Appl Environ Microbiol 2004; 70(9):5603–12; PMID:15345449; http://dx.doi.org/10.1128/AEM.70.9.5603-5612.2004
   PubMed Web of Science ®Google Scholar
• Kumar RS, Brannigan JA, Prabhune AA, Pundle AV, Dodson GG, Dodson EJ, Suresh CG. Structural and functional analysis of a conjugated bile salt hydrolase from Bifidobacterium longum reveals an evolutionary relationship with penicillin V acylase. J Biol Chem 2006 Oct 27; 281(43):32516–25; http://dx.doi.org/10.1074/jbc.M6041-72200
   PubMed Web of Science ®Google Scholar
• Coleman JP, Hudson LL. Cloning and characterization of a conjugated bile acid hydrolase gene from Clostridium perfringens. Appl Environ Microbiol 1995; 61(7):2514–20; PMID:7618863
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Kang DJ, Hylemon PB, Bajaj JS. Bile acids and the gut microbiome. Curr Opin Gastroenterol 2014; 30(3):332–8; PMID:24625896; http://dx.doi.org/10.1097/MOG.0000000000000057
   PubMed Web of Science ®Google Scholar
• Lin J, Sahin O, Michel LO, Zhang Q. Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect Immun 2003; 71(8):4250–59; PMID:12874300; http://dx.doi.org/10.1128/IAI.71.8.4250-4259.2003
   PubMed Web of Science ®Google Scholar
• Yokota A, Veenstra M, Kurdi P, van Veen HW, Konings WN. Cholate resistance in Lactococcus lactis is mediated by an ATP-dependent multispecific organic anion transporter. J Bacteriol 2000; 182(18):5196–201; PMID:10960105; http://dx.doi.org/10.1128/JB.182.18.5196-5201.2000
   PubMed Web of Science ®Google Scholar
• Fernandez Murga ML, Bernick D, de Valdez GF, Disalvo AE. Permeability and stability properties of membranes formed by lipids extracted from Lactobacillus acidophilus grown at different temperatures. Arch Biochem Biophys 1999; 364:115–121; PMID:10087172; http://dx.doi.org/10.1006/abbi.1998.1093
   PubMed Web of Science ®Google Scholar
• Kimoto H, Ohmomo S, Okamoto T. Enhancement of bile tolerance in Lactococci by Tween 80. J Appl Micro 2002; 92:41–46; http://dx.doi.org/10.1046/j.1365-2672.2002.01505.x
   PubMed Web of Science ®Google Scholar
• Liu Y, An H, Zhang J, Zhou J, Zhou H, Ren F, Hao Y. Functional role of tlyC1 encoding a hemolysin-like protein from Bifidobacterium longum BBMN68 in bile tolerance. FEMS Microbiol Lett 2014; 360:167–73; PMID:25227940; http://dx.doi.org/10.1111/1574-6968.12601
   PubMed Web of Science ®Google Scholar
• Ruiz L, Couté Y, Sánchez B, de los Reyes-Gavilán CG, Sanchez J, Margolles A. The cell-envelope proteome of Bifidobacterium longum in an in vivo bile environment. Microbiology 2009; 155:957–67; PMID:19246766; http://dx.doi.org/10.1099/mic.0.024273-0
   PubMed Web of Science ®Google Scholar
• Coleman R, Lowe PJ, Billington D. Membrane lipid composition and susceptibility to bile salt damage. Biochim Biophys Acta 1980; 599(1):294–300; PMID:7397151; http://dx.doi.org/10.1016/0005-2736(80)90075-9
   PubMed Web of Science ®Google Scholar
• Heuman DM, Bajaj RS, Lin Q. Adsorption of mixtures of bile salt taurine conjugates to lecithin-cholesterol membranes: implications for bile salt toxicity and cytoprotection. J Lipid Res 1996; 37(3):562–73; PMID:8728319
   PubMed Web of Science ®Google Scholar
• Fujisawa T, Mori M. Influence of bile salts on beta-glucuronidase activity of intestinal bacteria. Lett Appl Microbiol 1996; 22(4):271–74; PMID:8934784; http://dx.doi.org/10.1111/j.1472-765X.1996.tb01159.x
   PubMed Web of Science ®Google Scholar
• Noh DO, Gilliland SE. Influence of bile on cellular integrity and beta-galactosidase activity of Lactobacillus acidophilus. J Dairy Sci 1993; 76(5):1253–59; PMID:8505417; http://dx.doi.org/10.3168/jds.S0022-0302(93)77454-8
   PubMed Web of Science ®Google Scholar
• Gómez Zavagilia A, Kociubinski G, Pérez P, Disalvo E, De Antoni G. Effect of bile on the lipid composition and surface properties of bifidobacteria. J Appl Microbiol 2002; 93(5):794–99; http://dx.doi.org/10.1046/j.1365-2672.2002.01747.x
   PubMed Web of Science ®Google Scholar
• Taranto MP, Perez-Martinez G, Font de Valdez G. Effect of bile acid on the cell membrane functionality of lactic acid bacteria for oral administration. Res Microbiol 2006; 157(8):720–25; PMID:16730163; http://dx.doi.org/10.1016/j.resmic.2006.04.002
   PubMed Web of Science ®Google Scholar
• Hofmann M, Schumann C, Zimmer G, Henzel K, Locher U, Leuschner U. LUV’s lipid composition modulates diffusion of bile acids. Chem Phys Lipid 2001; 110(2):165–71; http://dx.doi.org/10.1016/S0009-3084(01)00131-1
   PubMed Web of Science ®Google Scholar
• Schubert R, Jaroni H, Schoelmerich J, Schmidt KH. Studies on the mechanism of bile salt-induced liposomal membrane damage. Digestion 1983; 28(3):181–90; PMID:6365666; http://dx.doi.org/10.1159/000198984
   PubMed Web of Science ®Google Scholar
• Cabral DJ, Small DM, Lilly HS, Hamilton JA. Transbilayer movement of bile acids in model membranes. Biochemistry 1987; 26(7):1801–4; PMID:3593691; http://dx.doi.org/10.1021/bi00381a002
   PubMed Web of Science ®Google Scholar
• Prouty AM, Schwesinger WH, Gunn JS. Biofilm formation and interaction with the surfaces of gallstones by Salmonella spp. Infect Immunol 2002; 70:2640–49; http://dx.doi.org/10.1128/IAI.70.5.2640-2649.2002
   PubMed Web of Science ®Google Scholar
• Hildebrandt MA, Hoffman C, SHerill-Mix SA, Keilbaugh SA, Hamady M, Chen YY, Knight R, Ahima RS, Bushman F, Wu GD. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009; 137(5):1716–24; PMID:19706296; http://dx.doi.org/10.1053/j.gastro.2009.08.042
   PubMed Web of Science ®Google Scholar
• Floch MH, Binder HJ, Filburn B, Gershengorn W. The effect of bile acids on intestinal microflora. Am J Clin Nutr 1972; (12):1418–26; PMID:4344803
   PubMed Web of Science ®Google Scholar
• Kurdi P, Kawanishi K, Mizutani K, Yokota A. Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria. J Bacteriol 2006; 188(5):1979–86; PMID:16484210; http://dx.doi.org/10.1128/JB.188.5.1979-1986.2006
   PubMed Web of Science ®Google Scholar
• Grill JP, Cayuela C, Antoine JM, Schneider F. Isolation and characterization of a Lactobacillus amylovorus mutant depleted in conjugated bile salt hydrolase activity: relation between activity and bile salt resistance. J Appl Microbiol 2000; 89:553–563; PMID:11054157; http://dx.doi.org/10.1046/j.1365-2672.2000.01147.x
   PubMed Web of Science ®Google Scholar
• Dussurget O, Cabanes D, Dehoux P, Lecuit M, Buchrieser C, Glaser P, Cossart P, European Listeria Genome Consortoum. Mol Microbiol 2002; 10(5):238–45
   Google Scholar
• Dussurget O, Cabanes D, Dehoux P, Lecuit M, Buchrieser C, Glaser P, Cossart P; European Listeria Genome Consortium. Listeria monocytogenes bile salt hydrolase is a PrfA-regulated virulence factor involved in the intestinal and hepatic phases of listeriosis. Mol Microbiol 2002 Aug; 45(4):1095–106; http://dx.doi.org/10.1046/j.1365-2958.2002.03080.x
   PubMed Web of Science ®Google Scholar
• Dunne C, O’Mahony L, Murphy L, Thornton G, Morrissey D, O’Halloran S, Feeney M, Flynn S, Fitzgerald G, Daly C, et al. In vitro selection criteria for probiotic bacteria of human origin: correlations with in vivo findings. Am J Clin Nutr 2001; 73(2 Suppl):386S–92S; PMID:11157346
   PubMedGoogle Scholar
• Huijghebaert SM, Eyssen HJ. Specificity of bile salt sulfatase activity from Clostridium sp. strains S1. Appl Environ Microbiol 1982; 44(5):1030–1034; PMID:7181500
   PubMed Web of Science ®Google Scholar
• Van Eldere J, Celis P, De Pauw G, Lesaffre E, Eyssen H. Tauroconjugation of cholic acid stimulates 7 alpha-dehydroxylation by fecal bacteria. Appl Environ Microbiol 1996; 62(2):656–661; PMID:8593067
   PubMed Web of Science ®Google Scholar
• Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 2012; 487(7405):104–8; PMID:22722865
   PubMed Web of Science ®Google Scholar
• Guilbert JJ. The world health report 2002-reducing risks, promoting healthy life. Educ Health 2003; 16(2):230; http://dx.doi.org/10.1080/1357628031000116808
   PubMedGoogle Scholar
• Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ 1990; 301:309–14; PMID:2144195; http://dx.doi.org/10.1136/bmj.301.6747.309
   PubMed Web of Science ®Google Scholar
• Evans M, Roberts S, Davies S, Rees A. Medical lipid-regulating therapy: current evidence, ongoing trails and future developments. Drugs 2004; 64(11):1181–96; PMID:15161326; http://dx.doi.org/10.2165/00003495-200464110-00003
   PubMed Web of Science ®Google Scholar
• Jones ML, Tomaro-Duchesneau C, Martoni CJ, Prakash S. Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications. Expert Opin Biol Ther 2013; 13(5):631–642; PMID:23350815; http://dx.doi.org/10.1517/14712598.2013.758706
   PubMed Web of Science ®Google Scholar
• Begley M, Hill C, Gahan CG. Bile salt hydrolase activity in probiotics. Appl Environ Microbiol 2006; 72(3):1729–38; PMID:16517616; http://dx.doi.org/10.1128/AEM.72.3.1729-1738.2006
   PubMed Web of Science ®Google Scholar
• Gustafsson BE, Midvedt T, Norman A. Metabolism of cholic acid in germfree animals after the establishment in the intestinal tract of deconjugating and 7alpha-dehydroxylating bacteria. Acta Pathol Microbiol Scand 1968; 72(3):433–43; PMID:4297296; http://dx.doi.org/10.1111/j.1699-0463.1968.tb00457.x
   PubMedGoogle Scholar
• Narushima S, Itoha K, Miyamoto Y, Park SH, Nagata K, Kuruma K, Uchida K. Deoxycholic acid formation in gnotobiotic mice associated with human intestinal bacteria. Lipids 2006; 41(9):835–43; PMID:17152920; http://dx.doi.org/10.1007/s11745-006-5038-1
   PubMed Web of Science ®Google Scholar
• Wells JE, Berr F, Thomas LA, Dowling RH, Hylemon PB. Isolation and characterization of cholic acid 7alpha-dehydroxylating fecal bacteria from cholesterol gallstone patients. J Hepatol 2000; 32(1):4–10; PMID:10673060; http://dx.doi.org/10.1016/S0168-8278(00)80183-X
   PubMed Web of Science ®Google Scholar
• Takamine F, Imamura T. Isolation and characterization of bile acid 7-dehydroxylating bacteria from human feces. Microbiol Immunol 1995; 39(1):11–8; PMID:7783673; http://dx.doi.org/10.1111/j.1348-0421.1995.tb02162.x
   PubMed Web of Science ®Google Scholar
• Hirano S, Nakama R, Tamaki M, Masuda N, Oda H. Isolation and characterization of thirteen intestinal microorganisms capable of 7alpha-dehydroxylating bile acids. Appl Environ Microbiol 1981; 41(3):737–45; PMID:7224633
   PubMed Web of Science ®Google Scholar
• Eyssen HJ, De Pauw G, Van Eldere J. Formation of hyodeoxycholic acid from muricholic acid and hyocholic acid by an unidentified gram-positive rod termed HDCA-1 isolated from rat intestinal microflora. Appl Environ Microbiol 1999; 65(7):3158–63; PMID:10388717
   PubMed Web of Science ®Google Scholar
• Sacquet EC, Gadelle DP, Riottot MJ, Raibaud PM. Absence of transformation of beta-muricholic acid by human microflora implanted in the digestive tracts of germfree male rats. Appl Environ Microbiol 1984; 47(5):1167–68; PMID:6742831
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Hylemon PB. Identification and characterization of two bile acid coenzyme A transferases from Clostridium scindens, a bile acid 7alpha-dehydroxylating bacterium. J Lipid Res 2012; 53(1):66–76; PMID:22021638; http://dx.doi.org/10.1194/jlr.M020313
   PubMed Web of Science ®Google Scholar
• Mallonee DH, Adams JL, Hylemon PB. The bile acid-inducible baiB gene from Eubacterium sp. strain VPI 12708 encodes a bile acid-coenzyme A ligase. 1992; 174(7):2065–71; PMID:1551828
   PubMedGoogle Scholar
• Dawson JA, Mallonee DH, Björkhem I, Hylemon PB. Expression and characterization of a C24 bile acid 7 alpha-dehydratase from Eubacterium sp. strain VPI 12708 in Escherichia coli. J Lipid Res 1996; 37(6):1258–67; PMID:8808760
   PubMed Web of Science ®Google Scholar
• Coleman JP, White WB, Hylemon PB. Molecular cloning of bile acid 7-dehydroxylase from Eubacterium sp. strain VPI 12708. J Bacteriol 1987; 169(4):1516–21; PMID:3549693
   PubMed Web of Science ®Google Scholar
• Kang DJ, Ridlon JM, Moore DR 2nd, Barnes S, Hylemon PB. Clostridium scindens baiCD and baiH genes encode stereo-specific 7alpha/7beta-hydroxy-3-oxo-delta-4-cholenoic acid oxidoreductases. Biochim Biophys Acta 2008; 1781(1-2):16–25; PMID:18047844; http://dx.doi.org/10.1016/j.bbalip.2007.10.008
   PubMed Web of Science ®Google Scholar
• Winter J, Morris GN, O’Rourke-Locascio S, Bokkenheuser VD, Mosbach EH, Cohen BI, Hylemon PB. Mode of action of steroid desmolase and reductases synthesized by Clostridium “scindens” (formerly Clostridium strain 19). J Lipid Res 1984; 25(10):1124–31; PMID:6512418
   PubMed Web of Science ®Google Scholar
• Bokkenheuser VD, Morris GN, Ritchie AE, Holdeman LV, Winter J. Biosynthesis of androgen from cortisol by a species of Clostridium recovered from human fecal flora. J Infect Dis 1984; 149(4):489–94; PMID:6725987; http://dx.doi.org/10.1093/infdis/149.4.489
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Ikegawa S, Alves JM, Zhou B, Kobayaski A, Iida T, Mitamura K, Tanabe G, Serrano M, De Guzman A, et al. Clostridium scindens: a human gut microbe with high potential to convert glucocorticoids into androgens. J Lipid Res 2013; 54(9):2437–49; PMID:23772041; http://dx.doi.org/10.1194/jlr.M038869
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Bajaj JS. The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics. Acta Pharmaceutica Sinica B 2015; 5(2):99–105; PMID:26579434; http://dx.doi.org/10.1016/j.apsb.2015.01.006
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Kang DJ, Hylemon PB. Isolation and characterization of a bile acid inducible 7alpha-dehydroxylating operon in Clostridium hylemonae TN271. Anaerobe 2010; 16(2):137–46; PMID:19464381; http://dx.doi.org/10.1016/j.anaerobe.2009.05.004
   PubMed Web of Science ®Google Scholar
• Mallonee DH, Hylemon PB. Sequencing and expression of a gene encoding a bile acid transporter from Eubacterium sp. strain VPI 12708. J Bacteriol 1996; 178(24):7053–58; PMID:8955384
   PubMed Web of Science ®Google Scholar
• Mallonee DH, Lijewski MA, Hylemon PB. Expression in Escherichia coli and characterization of a bile acid-inducible 3 alpha-hydroxysteroid dehydrogenase from Eubacterium sp. strain VPI 12708. Curr Microbiol 1995; 30(5):259–63; PMID:7766153; http://dx.doi.org/10.1007/BF00295498
   PubMed Web of Science ®Google Scholar
• Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013; 499(7456):97–101; PMID:23803760
   PubMed Web of Science ®Google Scholar
• Ou J, Carbonero F, Zoetendal EG, DeLany JP, Wang M, Newton K, Gaskins HR, O’Keefe SJ. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr 2013; 98(1):111–20; PMID:23719549; http://dx.doi.org/10.3945/ajcn.112.056689
   PubMed Web of Science ®Google Scholar
• David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischach MA, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505(7484):559–63; PMID:24336217; http://dx.doi.org/10.1038/nature12820
   PubMed Web of Science ®Google Scholar
• O’Keefe DJ, Li JV, Lahti L, Ou J, Carbonero F, Mohammed K, Posma JM, Kinross J, Wahl E, Ruder E, et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun 2015; 6:6342; http://dx.doi.org/10.1038/ncomms7342
   PubMed Web of Science ®Google Scholar
• Islam KB, Fukiya S, Hagio M, Fujii N, Ischizuka S, Ooka T, Ogura Y, Hayashi T, Yokota A. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 2011; 141(5):1773–81; PMID:21839040; http://dx.doi.org/10.1053/j.gastro.2011.07.046
   PubMed Web of Science ®Google Scholar
• Bhowmik S, Jones DH, Chiu HP, Park IH, Chiu HJ, Axelrod HL, Farr CL, Tien HJ, Agarwalla S, Lesley SA. Structural and functional characterization of BaiA, an enzyme involved in secondary bile acid synthesis in human gut microbe. Proteins 2014; 82(2):216–29; PMID:23836456; http://dx.doi.org/10.1002/prot.24353
   PubMed Web of Science ®Google Scholar
• Bhowmik B, Chiu H-P, Jones DH, Chiu H-J, Miller MD, Xu Q, Farr CL, Ridlon JM, Wells JE, Elsliger M-A et al. Structure and functional characterization of a Bile Acid 7α dehydratase BaiE in secondary bile acid synthesis. Proteins 2015; in press; PMID:26650892; http://dx.doi.org/10.1002/prot.2471 after 2015
   PubMedGoogle Scholar
• Korpela JT, Fotsis T, Adlercreutz H. Multicomponent analysis of bile acids in faeces by anion exchange and capillary column gas-liquid chromatography: application in oxytetracycline treated subjects. J Steroid Biochem 1986; 25(2):277-84.7; PMID:3747527; http://dx.doi.org/10.1016/0022-4731(86)90429-2
   PubMedGoogle Scholar
• Kakiyama G, Muto A, Takei H, Nittono H, Murai T, Kurosawa T, Hofmann AF, Pandak WM, Bajaj JS. A simple and accurate HPLC method for fecal bile acid profile in healthy and cirrhotic subjects: validation by GC-MS and LC-MS. J Lipid Res 2014; 55(5):978–90; PMID:24627129; http://dx.doi.org/10.1194/jlr.D047506
   PubMed Web of Science ®Google Scholar
• Kelsey MI, Molina JE, Huang SK, Hwang KK. The identification of microbial metabolites of sulfolithocholic acid. J Lipid Res 1980; 21(6)751–9.6; PMID:7419986
   PubMed Web of Science ®Google Scholar
• Benson GM, Haskins NJ, Eckers C, Moore PJ, Reid DG, Mitchell RC, Waghmare S, Suckling KE. Polydeoxycholate in human and hamster feces: a major product of cholate metabolism. J Lipid Res 1993; 34(12):2121–34.1; PMID:8301231
   PubMed Web of Science ®Google Scholar
• Studer E, Zhou X, Zhao R, Wang Y, Takabe K, Nagahashi M, Pandak WM, Dent P, Spiegel S, Shi R, et al. Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes. Hepatology 2012 Jan; 55(1):267–76; http://dx.doi.org/10.1002/hep.24681
   PubMed Web of Science ®Google Scholar
• Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, Sidaway JE, Nicholson JK, Holmes E. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci U S A 2009; 108 Suppl 1:4523–30
   Google Scholar
• Berr F, Kullak-Ublick GA, Paumgartner G, Münzing W, Hylemon PB. 7α-dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones. Gastroenterology 1996; 111(6):1611–201; PMID:8942741; http://dx.doi.org/10.1016/S0016-5085(96)70024-0
   PubMed Web of Science ®Google Scholar
• Thomas LA, Veysey MJ, Murphy GM, Russell-Jones D, French GL, Wass JA, Dowling RH. Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly Gut 2005; 54(5):630–5; PMID:15831907
   PubMed Web of Science ®Google Scholar
• Heuman DM. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 1989; 30(5):719–30; PMID:2760545
   PubMed Web of Science ®Google Scholar
• Matsuoka K, Moroi Y. Micelle formation of sodium deoxycholate and sodium ursodeoxycholate (part 1). Biochim Biophys Acta. 2002; 1580(2-3):189–99; PMID:11880243; http://dx.doi.org/10.1016/S1388-1981(01)00203-7
   PubMed Web of Science ®Google Scholar
• Devlin AS, Fischbach MA. A biosynthetic pathway for a prominent class of microbiota-derived bile acids. Nat Chem Biol 2015; 11(9):685–90; PMID:26192599; http://dx.doi.org/10.1038/nchembio.1864
   PubMed Web of Science ®Google Scholar
• Odermatt A, Da Cunha T, Penno CA, Chandsawangbhuwana C, Reichert C, Wolf A, Dong M, Baker ME. Hepatic reduction of the secondary bile acid 7-oxolithocholic acid is mediated by 11beta-hydroxysteroid dehydrogenase 1. Biochem J 2011; 436(3):621–9; PMID:21453287; http://dx.doi.org/10.1042/BJ20110022
   PubMed Web of Science ®Google Scholar
• Odermatt A, Klusonova P. 11beta-Hydroxysteroid dehydrogenase 1: Regeneration of active glucocorticoids is only part of the story. J Steroid Biochem Mol Biol 2015; 151:85–92; PMID:25151952; http://dx.doi.org/10.1016/j.jsbmb.2014.08.011
   PubMed Web of Science ®Google Scholar
• Hase K, Eckmann L, Leopard JD, Varki N, Kagnoff MF. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 2002; 70(2):953–63; PMID:11796631; http://dx.doi.org/10.1128/IAI.70.2.953-963.2002
   PubMed Web of Science ®Google Scholar
• Campbell Y, Fantacone ML, Gombart AF. Regulation of antimicrobial peptide gene expression by nutrients and by-products of microbial metabolism. Eur J Nutr 2012; 51(8):899–907; PMID:22797470; http://dx.doi.org/10.1007/s00394-012-0415-4
   PubMed Web of Science ®Google Scholar
• Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 1999; 3(5):543–53; PMID:10360171; http://dx.doi.org/10.1016/S1097-2765(00)80348-2
   PubMed Web of Science ®Google Scholar
• Fujino T, Une M, Imanaka T, Inoue K, Nishimaki-Mogami T. Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation. J Lipid Res 2004; 45(1):132–8; PMID:13130122; http://dx.doi.org/10.1194/jlr.M300215-JLR200
   PubMed Web of Science ®Google Scholar
• Hase K, Murakami M, Iimura M, Cole SP, Horibe Y, Ohtake T, et al. Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology 2003; 125(6):1613–25; PMID:14724813; http://dx.doi.org/10.1053/j.gastro.2003.08.028
   PubMed Web of Science ®Google Scholar
• Hofmann AF, Hagey LR. Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades. J Lipid Res 2014; 55(8):1553–1595; http://dx.doi.org/10.1194/jlr.R049437
   PubMed Web of Science ®Google Scholar
• Guarino MP, Cocca S, Altomare A, Emerenziani S, Cicala M. Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed. World J. Gastroenterol 2013; 19(31):5029–5034
   Web of Science ®Google Scholar
• Czul F, Peyton A, Levy C. Primary biliary cirrhosis: therapeutic advances. Clin Liver Dis 2013.17(2):229–242; PMID:23540499; http://dx.doi.org/10.1016/j.cld.2012.12.003
   PubMed Web of Science ®Google Scholar
• Mahmoud MF, Elshazly SM. Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats. PLoS One 2014; 9(9):e106993; PMID:25202970; http://dx.doi.org/10.1371/journal.pone.0106993
   PubMed Web of Science ®Google Scholar
• ALberts DS, Martinez ME, Hess LM, Einspahr JG, Green SB, Bhattacharyya AK, Guillen J, Krutzsch M, Batta AK, Salen G, et al, Phoenix and Tucson Gastroenterologist Networks. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 2005; 97(11):846–53; PMID:15928305; http://dx.doi.org/10.1093/jnci/dji144
   PubMedGoogle Scholar
• Serfaty L. Chemoprevention of colorectal cancer with ursodeoxycholic acid: pro. Clin Res Hepatol Gastroenterol 2012; 36 Suppl 1:S53–S60; PMID:23141895; http://dx.doi.org/10.1016/S2210-7401(12)70022-0
   PubMedGoogle Scholar
• Carey EJ, Lindor KD. Chemoprevention of colorectal cancer with ursodeoxycholic acid: cons. Clin Res Hepatol Gastroenterol 2012; 36 Suppl 1:S61–S64
   PubMedGoogle Scholar
• Earnest DL, Holubec H, Wali RK, Jolley CS, Bissonette M, Bhattacharyya AK, Roy H, Khare S, Brasitus TA. Chemoprevention of azomethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid. Cancer Res 1994 Oct 1; 54(19):5071–4
   PubMed Web of Science ®Google Scholar
• Brasitus TA. Primary chemoprevention strategies for colorectal cancer: ursodeoxycholic acid and other agents. Gastroenterology 1995; 109(6):2036–38; PMID:7498674; http://dx.doi.org/10.1016/0016-5085(95)90776-9
   PubMed Web of Science ®Google Scholar
• Wali RK, Frawley BP Jr, Hartmann S, Roy HK, Khare S, Scaglione-Sewell BA, Earnest DL, Sitrin MD, Brasitus TA, Bissonnette M. Mechanism of action of chemopreventative ursodeoxycholate in the azomethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and –zeta. Cancer Res 1995 Nov 15; 55(22):5257–64
   PubMed Web of Science ®Google Scholar
• Im E, Martinez JD. Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells. J Nutr 2004; 134(2):483–86; PMID:14747693
   PubMed Web of Science ®Google Scholar
• Rodrigues CM, Fan G, Wong PY, Kren BT, Steer CJ. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 1998 Mar; 4(3):165–78
   PubMed Web of Science ®Google Scholar
• Kulkarni MS, Heidepriem PM, Yielding KL. Production by lithocholic acid of DNA strand breaks in L1210 cells. Cancer Res 1980; 40:2666–2669; PMID:7388816
   PubMed Web of Science ®Google Scholar
• Booth LA, Gilmore IT, Bilton RF. Secondary bile acid induced DNA damage in HT29 cells: are free radicals involved? Free Radic Res 1997; 26(2):135–44; PMID:9257125; http://dx.doi.org/10.3109/10715769709-097792
   PubMed Web of Science ®Google Scholar
• Kulkarni MS, Cox BA, Yielding KL. Requirements for induction of DNA strand breaks by lithocholic acid. Cancer Res 1982; 42(7):2792–95; PMID:7083168
   PubMed Web of Science ®Google Scholar
• Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nature Rev Microbiol 2009; 7:526–536; http://dx.doi.org/10.1038/nrmicro2164
   PubMed Web of Science ®Google Scholar
• Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015; 26; 372(9):825–34; http://dx.doi.org/10.1056/NEJMoa1408913
   PubMed Web of Science ®Google Scholar
• Wilson KH, Perini F. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immun 1988; 56:2610–14; PMID:3417352
   PubMed Web of Science ®Google Scholar
• Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP. The role of toxin A and toxin B in Clostridium difficile infection. Nature 2010; 467(7316):711–3; PMID:20844489; http://dx.doi.org/10.1038/nature09397
   PubMed Web of Science ®Google Scholar
• van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG, et al. Duodenal infusion of feces for recurrent Clostridium difficile. N Engl J Med 2013; 368(22):407–415; PMID:23323867; http://dx.doi.org/10.1056/NEJMoa1205037
   PubMed Web of Science ®Google Scholar
• Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 2015; 517(7533):205–8; PMID:25337874; http://dx.doi.org/10.1038/nature13828
   PubMed Web of Science ®Google Scholar
• Wilson KH. Eficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination. J Clin Microbiol 1983; (4):1017–9
   Google Scholar
• Wilson KH, Kennedy MJ, Fekety FR. Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile J Clin Microbiol 1982; (3):443–6
   Google Scholar
• Sorg JA, Sonenshein AL. Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol 2008; 190(7):2505–12; PMID:18245298; http://dx.doi.org/10.1128/JB.01765-07
   PubMed Web of Science ®Google Scholar
• Sorg JA, Sonenshein AL. Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid. J Bacteriol 2010; 192(19):4983–90; PMID:20675492; http://dx.doi.org/10.1128/JB.00610-10
   PubMed Web of Science ®Google Scholar
• Francis MB, Allen CA, Sorg JA. Muricholic acids inhibit Clostridium difficile spore germination and growth. PLoS One 2013; 8(9):e73653; PMID:24040011; http://dx.doi.org/10.1371/journal.pone.0073653
   PubMed Web of Science ®Google Scholar
• Francis MB, Allen CA, Shrestha R, Sorg JA. Bile acid recognition by the Clostridium difficile germinant receptor, CspC, is important for establishing infection. PLoS Pathog 2013; 9(5):e1003356; PMID:23675301; http://dx.doi.org/10.1371/journal.ppat.1003356
   PubMed Web of Science ®Google Scholar